KO · Healthcare

SK Bioscience Co Ltd (302440)

Biotechnology

SK Bioscience Co Ltd (302440) is listed on KO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 302440

P/E ratio

25.00

SK Bioscience Co Ltd (302440) — FAQ

What is 302440's P/E ratio?

The price-to-earnings (P/E) ratio for SK Bioscience Co Ltd (302440) is 25.00 (data as of 2026-05-24).

Does SK Bioscience Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for SK Bioscience Co Ltd (302440). Check the MyAverix Finance app for the latest dividend data.

What sector is SK Bioscience Co Ltd in?

SK Bioscience Co Ltd (302440) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 302440 listed on?

302440 is listed on KO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)